Lanean...
Non-vitamin K Antagonist Oral Anticoagulant After Acute Coronary Syndrome: Is There a Role?
Despite dual antiplatelet therapy (DAPT) including potent P2Y12 inhibitors, recurrent ischaemic events occur in a significant number of patients after acute coronary syndrome (ACS), warranting new antithrombotic strategies. Combinations of non-vitamin K antagonist oral anticoagulant (NOAC) with anti...
Gorde:
| Argitaratua izan da: | Interv Cardiol |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Radcliffe Cardiology
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5980653/ https://ncbi.nlm.nih.gov/pubmed/29928315 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15420/icr.2018:5:2 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|